ISSLS is grateful to Taisho Pharmaceutical for its ongoing support for this award. In 2021 there were no applicants for this award. The bursary will be carried forward to 2022.
Purpose: To promote research in the lumbar spine.
Description: The research proposal can be in basic science, biomechanics or clinical clinical. It will be judged on significance, quality of the hypothesis, experimental protocol and feasibility. Projects that intend to use the ISSLS funding to lead to other, larger funding sources are encouraged but must have a strong plan for further funding. The winning proposal will receive a US$20,000.00 award. The principal investigator must be less than 45 years of age. At least one investigator must be an ISSLS member. The research funds cannot be used as a salary for any of the investigators. The recipient will provide a progress report to the research committee in writing, prior to the annual meeting and present this report at the Fellowship Ceremony. The winner of this grant will be announced at 2021 ISSLS Virtual Meeting.
The ISSLS Research Grant is sponsored by Taisho Toyama Pharmaceuticals for US$20,000 per year. Research costs, only, will be covered by the award. No indirect/overhead costs will be covered by the award.
Research Grant Committee:
Secretary of ISSLS – Jeffrey Lotz (Chair)
ISSLS President – Scott Blumenthal
1st Vice President – Tim Yoon
2nd Vice President – Kazuhiro Chiba
Scientific Representatives – Christopher Colloca, Christy Tomkins-Lane and Hiroshi Hashizume
- Background, Identification of Critical Lack of Knowledge, Preliminary Data, Significance, Hypothesis, Specific Aims: 2 page limit
- Detailed Experimental Protocol to achieve each specific aim with expected findings and possible interpretations, pitfalls: 5 page limit
- Further funding plans: 1 page limit
- Reference: No limit
- Brief biography indicating the qualifications to perform the research of Principal Investigator and all Co-investigators (1 page limit per person).
- CV of PI and Co-investigators should be included.
E-mail the application to the ISSLS Administrative office email@example.com. Deadline for applications: February 28, 2022
- 2020: Dr Graciosa P. Teixeira, Institute of Orthopaedic Research and Biomechanics, Ulm University, Ulm, Germany.
Title: Does complement deficiency influence intervertebral disc phenotype? Insights from C6 and CD59 deficient mice organ culture investigations. Read Report
- 2019: Dr Olga Krupkova, Laboratory for Immunoengineering and Regenerative Medicine, Zurich, Switzerland.
Title: “Cell-based delivery of GDF-5 for regeneration of the intervertebral disc using CRISPR”. Read Report
Due to the cancellation of the 2020 Annual Meeting, this report will be available following the 2021 Virtual Annual Meeting.
- 2018: Hugo Massé-Alarie, The University of Queensland, Australia. Read Final Report, Read Progress Report